An important question for mid-cap investors right now is whether the current market uncertainty caused by Covid-19 will affect the share prices of companies like Zydus Wellness. Zydus Wellness shares are currently trading at 1274.25. T...
ZYDUSWELL — Zydus Wellness Share Price
- IN₹98.36bn
- IN₹100.05bn
- IN₹20.09bn
- 68
- 12
- 28
- 23
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 24.73 | ||
PEG Ratio (f) | 1.29 | ||
EPS Growth (f) | 23.79% | ||
Dividend Yield (f) | 0.74% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.03 | ||
Price to Tang. Book | 25.98 | ||
Price to Free Cashflow | 60.94 | ||
Price to Sales | 4.9 | ||
EV to EBITDA | 29.02 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.52% | ||
Return on Equity | 6.56% | ||
Operating Margin | 15.98% |
Financial Summary
Year End 31st Mar | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 5,210.2 | 8,423.8 | 17,668.2 | 18,666.7 | 20,091 | 22,561 | 25,030.86 | 34.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +22.7 | +17 | -26.28 | +13.95 | +44.09 | +27.08 | +8.85 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Latest News & Insights for ZYDUSWELL
Profile Summary
Zydus Wellness Limited is an India-based consumer wellness company. The Company operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands, such as Everyuth, Nutralite, Complan, Glucon-D, Sugarlite, Everyuth, Nycil and Sugar Free D’lite. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.
Directors
- Sharvil Patel NEC (42)
- Tarun Arora CEO
- Umesh Parikh CFO
- Dhanraj Dagar CCO
- Ashish Bhargava DRC
- Ganesh Nayak NED (59)
- Kulin Lalbhai IND (36)
- Srivishnu Nandyala IND
- Dharmishta Raval IND
- Savyasachi Sengupta IND (66)
- Belle Hegde NID (76)
- Indiraben Parikh NID (70)
- Last Annual
- March 31st, 2022
- Last Interim
- March 31st, 2022
- Incorporated
- November 1st, 1994
- Public Since
- October 16th, 1995
- No. of Employees
- 188
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
National Stock Exchange of India
- Shares in Issue
- 63,630,000

- Address
- House No. 6 & 7, Nr. Iscon Temple, AHMEDABAD, 380015
- Web
- http://www.zyduswellness.in/
- Phone
- +91 7926868100
- Auditors
- Mukesh M. Shah & Co.
Upcoming Events for ZYDUSWELL
Q1 2023 Zydus Wellness Ltd Earnings Release
Q2 2023 Zydus Wellness Ltd Earnings Release
Similar to ZYDUSWELL
Adani Wilmar
National Stock Exchange of India
ADF Foods
National Stock Exchange of India
Agri-Tech (India)
National Stock Exchange of India
Agro Tech Foods
National Stock Exchange of India
Ajooni Biotech
National Stock Exchange of India
FAQ
As of Today at 07:25 UTC, shares in Zydus Wellness are trading at IN₹1,545.75. This share price information is delayed by 15 minutes.
Shares in Zydus Wellness last closed at IN₹1,545.75 and the price had moved by -26.75% over the past 365 days. In terms of relative price strength the Zydus Wellness share price has underperformed the S&P BSE 100 Index by -31.72% over the past year.
The overall consensus recommendation for Zydus Wellness is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Zydus Wellness dividend yield is 0.32% based on the trailing twelve month period.
Last year, Zydus Wellness paid a total dividend of IN₹5.00, and it currently has a trailing dividend yield of 0.32%. We do not have any data on when Zydus Wellness is to next pay dividends.
We do not have data on when Zydus Wellness is to next pay dividends. The historic dividend yield on Zydus Wellness shares is currently 0.32%.
To buy shares in Zydus Wellness you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,545.75, shares in Zydus Wellness had a market capitalisation of IN₹98.36bn.
Here are the trading details for Zydus Wellness:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ZYDUSWELL
Based on an overall assessment of its quality, value and momentum Zydus Wellness is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Zydus Wellness is IN₹2,266.63. That is 46.64% above the last closing price of IN₹1,545.75.
Analysts covering Zydus Wellness currently have a consensus Earnings Per Share (EPS) forecast of IN₹61.69 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zydus Wellness. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -17.43%.
As of the last closing price of IN₹1,545.75, shares in Zydus Wellness were trading -18.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zydus Wellness PE ratio based on its reported earnings over the past 12 months is 24.73. The shares last closed at IN₹1,545.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Zydus Wellness' management team is headed by:
- Sharvil Patel - NEC
- Tarun Arora - CEO
- Umesh Parikh - CFO
- Dhanraj Dagar - CCO
- Ashish Bhargava - DRC
- Ganesh Nayak - NED
- Kulin Lalbhai - IND
- Srivishnu Nandyala - IND
- Dharmishta Raval - IND
- Savyasachi Sengupta - IND
- Belle Hegde - NID
- Indiraben Parikh - NID